  | | | | STOCKHOLM (Reuters) - Bankrupt Swedish automaker Saab has found a buyer, the administrator said on Wednesday, with media naming a Swedish-Chinese group as the investor. | | |  | | | | BRUSSELS (Reuters) - EU antitrust regulators are expected to set out their objections to Universal Music Group's $1.9 billion bid for rival EMI's recorded music unit in the coming days, a person familiar with the matter said on Wednesday. | | | | | | LONDON (Reuters) - Starved of finance from hard-pressed banks, private equity firms in Europe are sounding out yield-hungry pension funds, insurers and sovereign wealth funds as alternative sources of the finance they need to do deals. | | | | | | LONDON (Reuters) - British oil firm Cairn Energy said it agreed to buy UK-focused Nautical Petroleum for 414 million pounds ($644 million), its second North Sea acquisition as part of a move to balance its high-risk exploration strategy in Greenland. | | | | | | COPENHAGEN (Reuters) - Danish wind turbine maker Vestas Wind Systems is to sell a tower factory in Denmark to Chinese group Titan Wind Energy for an undisclosed sum, allowing the world's biggest wind turbine maker to cut costs. | | | | | | LONDON (Reuters) - U.S. drugmaker Upsher-Smith Laboratories is to buy British group Proximagen for 223 million pounds ($347 million) plus further payments potentially worth up to 134 million based on the success of two experimental drugs. | | | |  | | | | (Reuters) - Yahoo Inc and CNBC have formed a content sharing partnership, the companies said on Wednesday. | | | | | | OSLO (Reuters) - Norwegian oil company Statoil and China's Sinochem agreed to buy the Peregrino floating production, storage and offloading (FPSO) vessel from Maersk , the companies said on Tuesday. | | | | | MEXICO CITY (Reuters) - Mexico's Iusacell said on Tuesday it will announce a deal with Spain's Telefonica, an agreement that takes place as the Mexican cellphone company waits to learn whether regulators approved the sale of half of the firm to broadcaster Televisa. | | | | | | (Reuters) - Johnson & Johnson said it expects to complete its $19.7 billion purchase of Swiss medical device maker Synthes on Thursday and that the deal will slightly boost company profit this year, rather than being a moderate drag on earnings as previously expected. | | | |  |  | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | |  | |  | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment